By Denny Jacob
CVS Health shares edged down 3.1%, to $70.51, after downgrading its earnings projection for the year due to the effect of its biggest deals since the nearly $70 billion takeover of Aetna in 2018.
The healthcare company’s stock is on pace for a 52-week low and its lowest close since March 4, 2021, when it closed at $69.17.
…
Read the full article here